We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$5.52B
AUM Growth
+$521M
Cap. Flow
-$140M
Cap. Flow %
-2.54%
Top 10 Hldgs %
18.25%
Holding
2,631
New
84
Increased
230
Reduced
1,501
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Financials 13.44%
3 Healthcare 12.77%
4 Industrials 10.2%
5 Consumer Discretionary 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KURA icon
2051
Kura Oncology
KURA
$896M
$160K ﹤0.01%
9,638
MITT
2052
TPG Mortgage Investment Trust
MITT
$214M
$159K ﹤0.01%
3,154
CONN
2053
DELISTED
Conn's Inc.
CONN
$159K ﹤0.01%
6,959
ZUMZ icon
2054
Zumiez
ZUMZ
$319M
$159K ﹤0.01%
6,388
GMS
2055
DELISTED
GMS Inc
GMS
$159K ﹤0.01%
10,495
MSGS icon
2056
Madison Square Garden
MSGS
$9.94B
$159K ﹤0.01%
758
-13
-2% -$2.64K
XPRO icon
2057
Expro Ltd
XPRO
$2.1B
$158K ﹤0.01%
4,246
+2
+0% +$73
PRTA icon
2058
Prothena Corp
PRTA
$466M
$158K ﹤0.01%
13,019
RMR icon
2059
The RMR Group
RMR
$346M
$158K ﹤0.01%
2,584
SRNE
2060
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$157K ﹤0.01%
33,137
+2,926
+10% +$7.68K
ATH
2061
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$157K ﹤0.01%
3,848
-59
-2% -$2.52K
BGG
2062
DELISTED
Briggs & Stratton Corp.
BGG
$156K ﹤0.01%
13,214
-1,212
-8% -$15.8K
OXFD
2063
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$156K ﹤0.01%
9,065
ACBI
2064
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$156K ﹤0.01%
8,749
ATRS
2065
DELISTED
Antares Pharma, Inc.
ATRS
$156K ﹤0.01%
51,367
-245
-0.5% -$794
CWEN.A
2066
DELISTED
Clearway Energy Class A
CWEN.A
$156K ﹤0.01%
10,702
WSBF icon
2067
Waterstone Financial
WSBF
$385M
$156K ﹤0.01%
9,450
ANIK icon
2068
Anika Therapeutics
ANIK
$283M
$155K ﹤0.01%
5,141
ORBC
2069
DELISTED
ORBCOMM, Inc.
ORBC
$155K ﹤0.01%
22,897
-92
-0.4% -$735
ARQL
2070
DELISTED
Arqule Inc
ARQL
$155K ﹤0.01%
32,403
+1,459
+5% +$5.63K
HTBK
2071
DELISTED
Heritage Commerce
HTBK
$155K ﹤0.01%
12,780
IBCP icon
2072
Independent Bank Corp
IBCP
$854M
$154K ﹤0.01%
7,152
UCFC
2073
DELISTED
United Community Financial Corp
UCFC
$154K ﹤0.01%
16,444
-93
-0.6% -$880
SITC icon
2074
SITE Centers
SITC
$158M
$153K ﹤0.01%
14,418
-316
-2% -$3.19K
LSXMK
2075
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$153K ﹤0.01%
5,256
-81
-2% -$2.45K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q1 2019 Portfolio in Review

As of Q1 2019, Metropolitan Life Insurance Company (MetLife) held 2,631 positions worth $5.52B, up 10% from $5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q1 2019 filing shows 84 new, 230 increased, 1,501 reduced and 81 closed positions. Its largest new stake was Linde: 92,826 shares worth $16.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $38.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q1 2019 buy was Linde: 92,826 shares worth $16.3M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2019, an estimated $7.2M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q1 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $38.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $7.31M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 18% of its $5.52B portfolio in Q1 2019.
  • Metropolitan Life Insurance Company (MetLife) opened 84 new positions and closed 81 in Q1 2019.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 10% quarter-over-quarter to $5.52B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2019, filed 15 May 2019.